And They’re Off! First Stelara Biosimilar Enters European Markets

Stada And Alvotech Launch Their Partnered Uzpruvo Version Of Ustekinumab Across Europe

 
• By Dave Wallace

Stada and Alvotech have heralded the start of biosimilar competition to Stelara in Europe with the launch of their partnered Uzpruvo version.

Sprinter coming out of blocks on racetrack
Alvotech and Stada’s Uzpruvo is first off the blocks in Europe • Source: Shutterstock

More from Biosimilars

More from Products